Breaking News Instant updates and real-time market news.

ST

Sensata

$51.66

3.76 (7.85%)

07:55
12/13/17
12/13
07:55
12/13/17
07:55

Sensata price target raised to $62 from $57 at Oppenheimer

Oppenheimer analyst Christopher Glynn raised his price target for Sensata to $62 from $57 on valuation. The analyst reiterates an Outperform rating on the shares.

ST Sensata
$51.66

3.76 (7.85%)

07/26/17
OPCO
07/26/17
NO CHANGE
Target $53
OPCO
Outperform
Sensata price target raised to $53 from $48 at Oppenheimer
Oppenheimer analyst Christopher Glynn raised his price target for Sensata to $53 from $48 following quarterly results. The analyst reiterates an Outperform rating on the shares.
12/01/17
RHCO
12/01/17
DOWNGRADE
RHCO
Hold
Sensata downgraded to Hold from Buy at SunTrust
12/01/17
RHCO
12/01/17
DOWNGRADE
Target $52
RHCO
Hold
Sensata downgraded to Hold at SunTrust on lower sales growth view
As reported earlier, SunTrust analyst William Stein downgraded Sensata to Hold from Buy and lowered his price target to $52 from $55. Stein says that while the company's earnings growth still looks attractive relative to valuation, there is a risk of lower sales growth and high financial leverage. The analyst also notes that although Sensata has been aligned with "one of the fastest growing end markets in semis/components" - automotive - the company's organic revenue growth has been below the sector unit growth in the past 3 years. Stein adds that Sensata has also recently taken a more conservative view on growth, retreating from expectation of accelerating organic growth in FY18.
12/13/17
JPMS
12/13/17
NO CHANGE
Target $60
JPMS
Overweight
JPMorgan ups Sensata target to $60 on 'strong' 2020 guidance
JPMorgan analyst Samik Chatterjee raised his price target for Sensata to $60 from $56 following yesterday's investor day. The analyst says the company's 2020 outlook "comfortably surpassed investor expectations." He sees further upside in the shares from potential re-rating and keeps an Overweight rating on the name.

TODAY'S FREE FLY STORIES

VLRX

Valeritas

$1.52

-0.05 (-3.18%)

07:06
05/23/18
05/23
07:06
05/23/18
07:06
Hot Stocks
Valeritas' V-Go device shows benefits in type 2 diabetes »

Valeritas announced data…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

$70.40

-1.35 (-1.88%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Hot Stocks
Cubic's CTS unit awarded contract from SRTA in Atlanta »

Cubic Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Jun

TGT

Target

$75.42

-1.44 (-1.87%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Technical Analysis
Technical Take: Target falls sharply after earnings miss »

In pre-market trading the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 19

    Jun

REX

REX American Resources

$76.62

-0.5 (-0.65%)

07:05
05/23/18
05/23
07:05
05/23/18
07:05
Earnings
REX American Resources reports Q1 EPS $1.45 vs. 69c last year »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

ALKS

Alkermes

$45.58

0.35 (0.77%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Hot Stocks
Alkermes to present data on depression, schizophrenia portfolios at ASCP »

Alkermes announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 31

    Jan

KOOL

Cesca Therapeutics

$0.53

0.0307 (6.14%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Initiation
Cesca Therapeutics initiated  »

Cesca Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCI

Navigant Consulting

$24.00

-0.19 (-0.79%)

07:04
05/23/18
05/23
07:04
05/23/18
07:04
Hot Stocks
Navigant Consulting, Lumere announce collaboration to reduce clinical variation »

Navigant Consulting and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Jun

ACRX

AcelRx

$2.95

0.05 (1.72%)

07:03
05/23/18
05/23
07:03
05/23/18
07:03
Hot Stocks
Three Arch's shares of AcelRx stock acquired in deal led by Leerink Revelation »

AcelRx Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:02
05/23/18
05/23
07:02
05/23/18
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 5/18 MBA Mortgage…

ANTM

Anthem

$234.12

0.52 (0.22%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Hot Stocks
Anthem to acquire Aspire Health, financial terms not disclosed »

Anthem announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MINE

Minerco Resources

$0.00

(0.00%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Hot Stocks
Minerco acquires controlling interest in Priwen Systems »

Minerco announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XCRA

Xcerra

$14.01

0.31 (2.26%)

07:02
05/23/18
05/23
07:02
05/23/18
07:02
Earnings
Xcerra reports Q3 non-GAAP EPS 24c, consensus 20c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

SO

Southern Company

$43.55

0.13 (0.30%)

07:01
05/23/18
05/23
07:01
05/23/18
07:01
Hot Stocks
Southern Power to sell minority stake in solar portfolio for $1.175B to GAFG »

Southern Power, a U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

SPX

S&P 500

$0.00

(0.00%)

07:00
05/23/18
05/23
07:00
05/23/18
07:00
Technical Analysis
S&P 500: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACM

Aecom

$33.33

-0.02 (-0.06%)

07:00
05/23/18
05/23
07:00
05/23/18
07:00
Hot Stocks
Aecom awarded 15-year $3.1B U.S. Air Force contract »

AECOM's wholly owned…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AET

Aetna

$177.66

0.08 (0.05%)

, CVS

CVS Health

$65.59

0.09 (0.14%)

06:58
05/23/18
05/23
06:58
05/23/18
06:58
Recommendations
Aetna, CVS Health analyst commentary  »

Aetna risk/reward…

AET

Aetna

$177.66

0.08 (0.05%)

CVS

CVS Health

$65.59

0.09 (0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    May

  • 30

    May

FTR

Frontier Communications

$9.55

-0.06 (-0.62%)

06:58
05/23/18
05/23
06:58
05/23/18
06:58
Periodicals
Frontier in talks with bondholders after failed asset auction, Bloomberg reports »

Frontier Communications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TOL

Toll Brothers

$39.46

-4.14 (-9.50%)

06:55
05/23/18
05/23
06:55
05/23/18
06:55
Recommendations
Toll Brothers analyst commentary  »

Toll Brothers price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$183.81

-0.67 (-0.36%)

06:53
05/23/18
05/23
06:53
05/23/18
06:53
Periodicals
Facebook's upper ranks never seem to leave company, Recode reports »

Facebook's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Jun

TIF

Tiffany

$102.26

-0.96 (-0.93%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Hot Stocks
Breaking Hot Stocks news story on Tiffany »

Tiffany up 7.8% after…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

REGN

Regeneron

$294.72

-1.86 (-0.63%)

, SNY

Sanofi

$38.93

0.15 (0.39%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Recommendations
Regeneron, Sanofi analyst commentary  »

Regeneron product…

REGN

Regeneron

$294.72

-1.86 (-0.63%)

SNY

Sanofi

$38.93

0.15 (0.39%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    Aug

  • 20

    Oct

  • 28

    Jan

MRK

Merck

$58.46

-0.1 (-0.17%)

06:52
05/23/18
05/23
06:52
05/23/18
06:52
Hot Stocks
Merck announces Keytruda met the dual primary endpoints in KEYNOTE trial »

Merck announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 10

    Sep

  • 23

    Oct

TIF

Tiffany

$102.26

-0.96 (-0.93%)

06:51
05/23/18
05/23
06:51
05/23/18
06:51
Earnings
Tiffany raises FY18 EPS view to $4.50-$4.70, consensus $4.42 »

Management's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 26

    Jun

GDX

Market Vector Gold Miners

$22.12

-0.22 (-0.98%)

06:51
05/23/18
05/23
06:51
05/23/18
06:51
Technical Analysis
Market Vector Gold Miners: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLD

SPDR Gold Trust

$122.42

-0.05 (-0.04%)

06:50
05/23/18
05/23
06:50
05/23/18
06:50
Technical Analysis
SPDR Gold Trust: Pivot points, pivot high broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.